Old Mission Capital’s Genmab GMAB Stock Holding History

Old Mission Capital’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-78,905	Closed	-$2.43M	–	1162
2025 Q4	$2.43M	Buy	+78,905	New	+$2.46M	0.06%	170
2025 Q1	–	Sell	-111,601	Closed	-$2.33M	–	1044
2024 Q4	$2.33M	Buy	+111,601	New	+$2.45M	0.04%	197
2023 Q2	–	Sell	-38,552	Closed	-$1.46M	–	1407
2023 Q1	$1.46M	Buy	+38,552	New	+$1.48M	0.03%	383
2022 Q4	–	Sell	-9,733	Closed	-$313K	–	1553
2022 Q3	$313K	Buy	+9,733	New	+$342K	0.01%	683
2021 Q2	–	Sell	-12,549	Closed	-$412K	–	1105
2021 Q1	$412K	Buy	+12,549	New	+$472K	0.02%	555
2019 Q4	–	Sell	-208,363	Closed	-$4.22M	–	327
2019 Q3	$4.22M	Buy	+208,363	New	+$4.1M	0.53%	40

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Old Mission Capital's GMAB Position: Q1 2026 in Review

Old Mission Capital sold out of Genmab (GMAB) in Q1 2026, closing a stake of 78,905 shares — an estimated $2.43M sold.

Old Mission Capital first reported a position in GMAB in Q3 2019 and held it in 6 quarters. The position peaked at $4.22M in Q3 2019. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

Old Mission Capital reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
Old Mission Capital sold 78,905 Genmab shares in Q1 2026, an estimated $2.43M.
Old Mission Capital first reported a position in Genmab in Q3 2019 and held it in 6 quarters.
Old Mission Capital's Genmab position peaked at $4.22M in Q3 2019.
274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Old Mission Capital's 13F filing for Q1 2026, filed 15 May 2026.